Risk Assessment for HBV-Related Liver Cancer

Recruiting now

Conditions studied: HBV-related Liver Cirrhosis

In brief

Liver cancer is a severe disease worldwide. The incidence and mortality rates of liver cancer in China is the highest in the world. This project aims to perform a prospective, multi-center, large sample cohort study for HBV related high-risk individuals. Based on multimodal data fusion and AI technique, stratified management and follow-up system are conducted for HBV-related high-risk populations of liver cancer, in order to improve the early diagnosis rate of liver cancer.

Key facts

Study ID

NCT07160946

Run by

Sun Yat-sen University

People needed

6000

Starts

2025-05-10

Expected to finish

2032-12-30

Last updated by the study team

2025-09-08

Who can join

Age: 30 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• (a).Diagnosed with malignant tumors; (b). Post liver transplantation; (c). Infected with HIV; (d). Expected survival time<1 year; (e). With marked organ dysfunctions(heart, brain, kidney, lung, endocrine system, blood, etc.) or psychiatric patients.

Where it is running

• Third Affiliated Hospital of Sun Yat-sen University — Guangzhou, Guangdong, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.